Healthcare provider profile · identity verified

Oliver S. Wagner, M.D.

Family Practice · LANCASTER, PA · NPI 1588001713

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	530	140
Amlodipine Besylate	Amlodipine Besylate	429	110
Lisinopril	Lisinopril	387	107
Metformin Hcl Er	Metformin Hcl	317	80
Omeprazole	Omeprazole	315	79
Rosuvastatin Calcium	Rosuvastatin Calcium	315	92
Hydrochlorothiazide	Hydrochlorothiazide	266	71
Levothyroxine Sodium	Levothyroxine Sodium	260	68
Simvastatin	Simvastatin	242	57
Metoprolol Succinate	Metoprolol Succinate	234	64
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	210	48
Losartan Potassium	Losartan Potassium	210	60
Gabapentin	Gabapentin	205	49
Metformin Hcl	Metformin Hcl	189	47
Sertraline Hcl	Sertraline Hcl	171	40
Escitalopram Oxalate	Escitalopram Oxalate	152	37
Albuterol Sulfate Hfa	Albuterol Sulfate	148	68
Pantoprazole Sodium	Pantoprazole Sodium	139	38
Trulicity	Dulaglutide	125	27
Tamsulosin Hcl	Tamsulosin Hcl	117	31
Allopurinol	Allopurinol	114	25
Montelukast Sodium	Montelukast Sodium	102	28
Trazodone Hcl	Trazodone Hcl	93	24
Jardiance	Empagliflozin	92	23
Furosemide	Furosemide	91	30
Eliquis	Apixaban	88	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	77	21
Fluoxetine Hcl	Fluoxetine Hcl	72	12
Oxycodone Hcl	Oxycodone Hcl	72	13
Lorazepam	Lorazepam	70	suppressed
Pravastatin Sodium	Pravastatin Sodium	70	17
Citalopram Hbr	Citalopram Hydrobromide	69	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	69	20
Tizanidine Hcl	Tizanidine Hcl	68	26
Carvedilol	Carvedilol	67	17
Propranolol Hcl Er	Propranolol Hcl	63	13
Atenolol	Atenolol	61	15
Bupropion Xl	Bupropion Hcl	61	14
Warfarin Sodium	Warfarin Sodium	60	17
Fluticasone Propionate	Fluticasone Propionate	59	32
Meloxicam	Meloxicam	56	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	15
Glimepiride	Glimepiride	55	16
Breo Ellipta	Fluticasone/Vilanterol	52	suppressed
Clopidogrel	Clopidogrel Bisulfate	50	13
Synthroid	Levothyroxine Sodium	50	11
Spironolactone	Spironolactone	49	suppressed
Glipizide Er	Glipizide	45	12
Triamcinolone Acetonide	Triamcinolone Acetonide	45	18
Alendronate Sodium	Alendronate Sodium	44	11
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	44	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	15
Finasteride	Finasteride	41	11
Mirtazapine	Mirtazapine	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Alprazolam	Alprazolam	40	11
Buspirone Hcl	Buspirone Hcl	40	suppressed
Prednisone	Prednisone	40	33
Duloxetine Hcl	Duloxetine Hcl	39	12
Famotidine	Famotidine	37	11
Ozempic	Semaglutide	36	11
Xarelto	Rivaroxaban	36	suppressed
Donepezil Hcl	Donepezil Hcl	35	suppressed
Celecoxib	Celecoxib	31	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	11
Potassium Chloride	Potassium Chloride	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Liothyronine Sodium	Liothyronine Sodium	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Lovastatin	Lovastatin	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Ibandronate Sodium	Ibandronate Sodium	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Ramipril	Ramipril	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Pregabalin	Pregabalin	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	17
Doxepin Hcl	Doxepin Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Naproxen	Naproxen	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Diazepam	Diazepam	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Cephalexin	Cephalexin	13	13
Cimetidine	Cimetidine	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Amoxicillin	Amoxicillin	11	11
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error